Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Low-Dose Intravenous Dexamethasone and Parecoxib in Prevention of Post Embolization Syndrome
TCTR20260608003Phase 4Recruiting
- Sponsor
- Bhumibol Adulyadej Hospital
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, parecoxib in post-embolization syndrome (PES), sponsored by Bhumibol Adulyadej Hospital. Started May 2026; status: recruiting.
02
Drugs
dexamethasoneparecoxib
03
Conditions
post-embolization syndrome (PES)
Beyond the preview
Go deeper on TCTR20260608003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260608003.